Survival Rate of Dialysis Patients Has Improved
London, UK (May 27, 2015) - At least 70 million Europeans suffer from chronic kidney disease (CKD). However, dialysis patients represent only 1 to 2% of the CKD population. CKD is clearly a disease that progresses slowly, but steadily – yet even in its early stages, CKD causes a dramatic increase in general and cardiovascular mortality. The sad truth is that many CKD patients die before reaching end-stage renal disease (ESRD), when they are dependent on renal replacement therapy (dialysis, transplantation). Risk calculations indicate that CKD is a negative cardiovascular prognostic factor as such, irrespective of the traditional mortality risks such as cholesterol or blood pressure. Five years ago, a systematic analysis published in the renowned journal, ‘The Lancet’ , involving more than 1.2 million patients, showed that total as well as cardiovascular mortality can be well estimated using simple kidney function tests.